TFA
EVH icon

Transamerica Financial Advisors’s Evolent Health EVH Stock Holding History

Transamerica Financial Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113 Hold
21
– – ﹤0.01% 1978
2026
Q1 		$47 Buy
+21
New +$67 ﹤0.01% 1901

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Transamerica Financial Advisors's EVH Position: Q2 2026 in Review

Transamerica Financial Advisors held its Evolent Health (EVH) position steady in Q2 2026 at 21 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Transamerica Financial Advisors first reported a position in EVH in Q1 2026 and has held it in 2 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Transamerica Financial Advisors held 21 shares of Evolent Health worth $113 as of Q2 2026.
  • Transamerica Financial Advisors left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1978 holding.
  • Transamerica Financial Advisors first reported a position in Evolent Health in Q1 2026 and has held it in 2 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.